0
0
Home » Medical Devices » Diabetes Care Devices

Insulin Pumps and Continuous Glucose Monitors Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

The insulin pumps and continuous glucose monitors market size was valued at $10.71 billion in 2021. The insulin pumps and continuous glucose monitors market report is built to visualize quantitative market trends within diabetes care devices therapeutic area. The model discusses in detail the impact of COVID-19 on the insulin pumps and continuous glucose monitors market for the year 2020 and beyond.

Insulin pumps and continuous glucose monitors market outlook

Insulin pumps and continuous glucose monitors market outlook

 

For more insights on the report, download a free sample

Which are the key regions in the insulin pumps and continuous glucose monitors market?

The key regions in the insulin pumps and continuous glucose monitors market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

Which are the key countries in the insulin pumps and continuous glucose monitors market?

There are 39 key countries discussed in the insulin pumps and continuous glucose monitors market including Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US.

Which are the key segments in the insulin pumps and continuous glucose monitors market?

The key segments in the insulin pumps and continuous glucose monitors market are insulin pumps and blood glucose meters. Insulin pumps was the largest segment in 2021.

Insulin pumps and continuous glucose monitors market, by segments

Insulin pumps and continuous glucose monitors market, by segments

For more segment insights, download a free sample

Which are the key companies in the insulin pumps and continuous glucose monitors market?

The key companies in the insulin pumps and continuous glucose monitors market are Medtronic plc, Abbott Laboratories, DexCom Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and Zealand Pharma.

Insulin pumps and continuous glucose monitors market, by key companies

Insulin pumps and continuous glucose monitors market, by key companies

To know more about key companies, download a free sample

Market report overview

Market size 2021 $10.71 billion
Key regions North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa
Key countries Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US
Key segments Insulin pumps and Blood glucose meters
Key companies Medtronic plc, Abbott Laboratories, DexCom Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and Zealand Pharma

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

  • CMO executives who must have deep understanding of the Insulin Pumps and Continuous Glucose Monitors marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Insulin Pumps and Continuous Glucose Monitors market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Insulin Pumps and Continuous Glucose Monitors market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insulin Pumps and Continuous Glucose Monitors market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Insulin Pumps and Continuous Glucose Monitors from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.”

Key Players

Medtronic Plc

Abbott Laboratories

DexCom Inc

Insulet Corp

F. Hoffmann-La Roche Ltd

Ypsomed Holding AG

Tandem Diabetes Care Inc

Zealand Pharma AS

Others

Frequently Asked Questions

The insulin pumps and continuous glucose monitors market was valued at $10.71 billion in 2021.

North America, South & Central America, Europe, Asia-Pacific, and Middle East & Africa are the key regions in the insulin pumps and continuous glucose monitors market.

Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, Egypt, Finland, France, Greece, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Russia, Saudi-Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the UK, UAE, and the US are the key countries in the insulin pumps and continuous glucose monitors market.

Insulin pumps and blood glucose meters are the key segments in the insulin pumps and continuous glucose monitors market.

Medtronic plc, Abbott Laboratories, DexCom Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and Zealand Pharma are the key companies in the insulin pumps and continuous glucose monitors market.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports